Literature DB >> 16354690

Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4.

Jason D Grier1, Shunbin Xiong, Ana C Elizondo-Fraire, John M Parant, Guillermina Lozano.   

Abstract

The function of the p53 tumor suppressor to inhibit proliferation or initiate apoptosis is often abrogated in tumor cells. Mdm2 and its homolog, Mdm4, are critical inhibitors of p53 that are often overexpressed in human tumors. In mice, loss of Mdm2 or Mdm4 leads to embryonic lethal phenotypes that are completely rescued by concomitant loss of p53. To examine the role of Mdm2 and Mdm4 in a temporal and tissue-specific manner and to determine the relationships of these inhibitors to each other, we generated conditional alleles. We deleted Mdm2 and Mdm4 in cardiomyocytes, since proliferation and apoptosis are important processes in heart development. Mice lacking Mdm2 in the heart were embryonic lethal and showed defects at the time recombination occurred. A critical number of cardiomyocytes were lost by embryonic day 13.5, resulting in heart failure. This phenotype was completely rescued by deletion of p53. Mice lacking Mdm4 in the heart were born at the correct ratio and appeared to be normal. Our studies provide the first direct evidence that Mdm2 can function in the absence of Mdm4 to regulate p53 activity in a tissue-specific manner. Moreover, Mdm4 cannot compensate for the loss of Mdm2 in heart development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16354690      PMCID: PMC1317622          DOI: 10.1128/MCB.26.1.192-198.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.

Authors:  D A Sharp; S A Kratowicz; M J Sank; D L George
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

2.  MdmX protects p53 from Mdm2-mediated degradation.

Authors:  M W Jackson; S J Berberich
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 3.  p53: death star.

Authors:  K H Vousden
Journal:  Cell       Date:  2000-11-22       Impact factor: 41.582

4.  Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo.

Authors:  R Agah; P A Frenkel; B A French; L H Michael; P A Overbeek; M D Schneider
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

6.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

7.  Widespread recombinase expression using FLPeR (flipper) mice.

Authors:  F W Farley; P Soriano; L S Steffen; S M Dymecki
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

8.  Apoptosis and proliferation in the neonatal murine heart.

Authors:  E Fernandez; Z Siddiquee; R V Shohet
Journal:  Dev Dyn       Date:  2001-07       Impact factor: 3.780

9.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

Review 10.  Mdmx and Mdm2: brothers in arms?

Authors:  Jean-Christophe Marine; Aart G Jochemsen
Journal:  Cell Cycle       Date:  2004-07-02       Impact factor: 4.534

View more
  80 in total

Review 1.  Mouse models of p53 functions.

Authors:  Guillermina Lozano
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

2.  Turning the RING domain protein MdmX into an active ubiquitin-protein ligase.

Authors:  Saravanakumar Iyappan; Hans-Peter Wollscheid; Alejandro Rojas-Fernandez; Andreas Marquardt; Hao-Cheng Tang; Rajesh K Singh; Martin Scheffner
Journal:  J Biol Chem       Date:  2010-08-12       Impact factor: 5.157

3.  MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output.

Authors:  Lihong Chen; Zhenyu Li; Aleksandra K Zwolinska; Matthew A Smith; Brittany Cross; John Koomen; Zhi-Min Yuan; Thomas Jenuwein; Jean-Christophe Marine; Kenneth L Wright; Jiandong Chen
Journal:  EMBO J       Date:  2010-06-29       Impact factor: 11.598

4.  PRMT1-p53 Pathway Controls Epicardial EMT and Invasion.

Authors:  Olan Jackson-Weaver; Nicha Ungvijanpunya; Yuan Yuan; Jiang Qian; Yongchao Gou; Jian Wu; Hua Shen; Yibu Chen; Meng Li; Stéphane Richard; Yang Chai; Henry M Sucov; Jian Xu
Journal:  Cell Rep       Date:  2020-06-09       Impact factor: 9.423

5.  Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching.

Authors:  Sylvia Hilliard; Karam Aboudehen; Xiao Yao; Samir S El-Dahr
Journal:  Dev Biol       Date:  2011-03-21       Impact factor: 3.582

Review 6.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

7.  Guilty as CHARGED: p53's expanding role in disease.

Authors:  Jeanine L Van Nostrand; Laura D Attardi
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 8.  MdmX regulates transformation and chromosomal stability in p53-deficient cells.

Authors:  Zdenka Matijasevic; Anna Krzywicka-Racka; Greenfield Sluder; Stephen N Jones
Journal:  Cell Cycle       Date:  2008-10-15       Impact factor: 4.534

9.  Mdm2 and Mdm4 loss regulates distinct p53 activities.

Authors:  Juan A Barboza; Tomoo Iwakuma; Tamara Terzian; Adel K El-Naggar; Guillermina Lozano
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

Review 10.  Breaking down protein degradation mechanisms in cardiac muscle.

Authors:  Robert C Lyon; Stephan Lange; Farah Sheikh
Journal:  Trends Mol Med       Date:  2013-02-27       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.